{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:31:29Z","timestamp":1787923889143,"version":"build-2784847793"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite advances in targeted therapies, breast cancer remains one of the major challenges to global health. Although patient-derived organoids (PDOs) are physiologically relevant models, existing transcriptomic studies are limited by the poor integration of immune signals and the absence of shared biomarkers across subtypes. In this study, we hypothesised that an integrated transcriptomic and network-based analysis of PDOs could identify conserved transcriptional signatures and pathway interactions across breast cancer subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>PDOs representative of multiple breast cancer subtypes were analysed and compared with non-tumour organoids. Differential gene expression analysis was performed to identify transcriptional alterations, followed by pathway enrichment analysis and protein-protein interaction network analysis to investigate functional pathways and molecular interactions. Candidate biomarkers identified through computational analyses were subsequently validated experimentally by assessing gene expression and cytokine secretion profiles in tumour PDOs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 646 differentially expressed genes were identified. Pathway enrichment analysis revealed translational machinery and ribosome biogenesis as the dominant statistically significant processes, consistent with hyperactivated protein synthesis in cancer cells. Although neurotrophin signaling pathways were not enriched at the transcriptome-wide level, network analysis identified a computationally predicted functional association between IL1RAP and NTRK3 in the STRING database. SLITRK3, IL1RAP and IRF2BP2 were consistently overexpressed in tumour PDOs and associated with activation of inflammatory pathways and increased secretion of IL-1 and IFN-\u03b3. NTRK3 was identified as a direct network interactor of IL1RAP bridging inflammatory and neurotrophin signalling, though its transcriptional direction in BC PDOs could not be unambiguously resolved from the available data. Experimental validation confirmed the upregulation of SLITRK3, IL1RAP and IRF2BP2 together with elevated secretion of IL-1\u03b2 and IFN-\u03b3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our findings suggest that IL1RAP and IRF2BP2 may be important in immune-related and candidated biomarker identification in breast cancer PDOs. We integrated transcriptomic, enrichment and network-based analyses for a robust strategy for biomarker discovery. This methodologically transparent framework highlights potential targets in breast cancer. Rather than only a list of candidate genes, it provides an organoid-derived computational framework for risk stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fbioe.2026.1900123","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:53:02Z","timestamp":1787921582000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated transcriptomic and immune-associated network analysis of breast cancer patient-derived organoids reveals candidate inflammatory biomarkers"],"prefix":"10.3389","volume":"14","author":[{"given":"S.","family":"Scippa","sequence":"first","affiliation":[{"name":"IRCCS SYNLAB SDN","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Balestrieri","sequence":"additional","affiliation":[{"name":"IRCCS SYNLAB SDN","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zanfardino","sequence":"additional","affiliation":[{"name":"IRCCS SYNLAB SDN","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salvatore","sequence":"additional","affiliation":[{"name":"IRCCS SYNLAB SDN","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Soricelli","sequence":"additional","affiliation":[{"name":"Department of Medical, Movement and Well-being Sciences, University of Naples Parthenope","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"D\u2019aiuto","sequence":"additional","affiliation":[{"name":"Clinica Villa Fiorita","place":["Aversa, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mossetti","sequence":"additional","affiliation":[{"name":"Pathological Anatomy Service, Maria Rosaria Clinic","place":["Pompei\/Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ciaramella","sequence":"additional","affiliation":[{"name":"IRCCS SYNLAB SDN","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s43556-021-00051-2","article-title":"Role of novel cancer gene SLITRK3 to activate NTRK3 in squamous cell lung cancer","volume":"2","author":"Bollig-Fischer","year":"2021","journal-title":"Mol. Biomed."},{"key":"B2","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.3390\/curroncol29110640","article-title":"Expression and signaling pathways of Nerve Growth Factor (NGF) and Pro-NGF in breast cancer: a systematic review","volume":"29","author":"Bruno","year":"2022","journal-title":"Curr. Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-Gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/medicina61030474","article-title":"Neurotrophic receptor tyrosine kinase 3 as a prognostic biomarker in breast cancer using bioinformatic analysis","volume":"61","author":"Choi","year":"2025","journal-title":"Med. Kaunas."},{"key":"B5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/bfgp\/elq021","article-title":"Gene set enrichment; a problem of pathways","volume":"9","author":"Davies","year":"2010","journal-title":"Brief. Funct. Genomics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s13046-019-1257-1","article-title":"Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures","volume":"38","author":"Della Corte","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1038\/sj.onc.1206805","article-title":"Nerve growth factor overexpression and autocrine loop in breast cancer cells","volume":"22","author":"Doll\u00e9","year":"2003","journal-title":"Oncogene"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/0008-5472.CAN-21-4087","article-title":"Ribosome biogenesis: a central player in cancer metastasis and therapeutic resistance","volume":"82","author":"Elhamamsy","year":"2022","journal-title":"Cancer Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","article-title":"A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology","volume":"3","author":"Guillen","year":"2022","journal-title":"Nat. Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12943-025-02336-4","article-title":"Cancer-nervous system crosstalk: from biological mechanism to therapeutic opportunities","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"135658","DOI":"10.1016\/j.neulet.2021.135658","article-title":"Mini-review: trophic interactions between cancer cells and primary afferent neurons","volume":"746","author":"Hunt","year":"2021","journal-title":"Neurosci. Lett."},{"key":"B13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/cancers12010147","article-title":"Roles of TrkC signaling in the regulation of tumorigenicity and metastasis of cancer","volume":"12","author":"Jin","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","article-title":"Next-generation cancer organoids","volume":"21","author":"LeSavage","year":"2022","journal-title":"Nat. Mater"},{"key":"B16","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/s41591-023-02276-w","article-title":"Tumor inflammation-associated neurotoxicity","volume":"29","author":"Mahdi","year":"2023","journal-title":"Nat. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.1158\/0008-5472.CAN-08-1357","article-title":"SLITs suppress tumor growth in vivo by silencing Sdf1\/Cxcr4 within breast epithelium","volume":"68","author":"Marlow","year":"2008","journal-title":"Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3892\/ol.2018.9854","article-title":"Targeting the BDNF\/TrkB pathway for the treatment of tumors","volume":"17","author":"Meng","year":"2019","journal-title":"Oncol. Lett."},{"key":"B19","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.neo.2018.05.002","article-title":"Carcinogenesis as a result of multiple inflammatory and oxidative hits: a comprehensive review from tumor microenvironment to gut microbiota","volume":"20","author":"Morgillo","year":"2018","journal-title":"Neoplasia"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.36255\/exon-publications-breast-cancer-subtypes","article-title":"Subtypes of breast cancer","volume-title":"Breast Cancer","author":"Orrantia-Borunda","year":"2022"},{"key":"B21","doi-asserted-by":"publisher","first-page":"655307","DOI":"10.3389\/fcell.2021.65530","article-title":"The transcriptional Co-factor IRF2BP2: a new player in tumor development and microenvironment","volume":"9","author":"Pastor","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1475-2867-11-23","article-title":"Brain-derived neurotrophic factor expression predicts adverse pathological and clinical outcomes in human breast cancer","volume":"11","author":"Patani","year":"2011","journal-title":"Cancer Cell Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc.2017.104","article-title":"Ribosome biogenesis in cancer: new players and therapeutic avenues","volume":"18","author":"Pelletier","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/biomedicines11030773","article-title":"The role of patient-derived organoids in triple-negative breast cancer drug screening","volume":"11","author":"Psilopatis","year":"2023","journal-title":"Biomedicines"},{"key":"B25","doi-asserted-by":"publisher","first-page":"14430","DOI":"10.1038\/srep14430","article-title":"Low expression of Slit2 and Robo1 is associated with poor prognosis and brain-specific metastasis of breast cancer patients","volume":"5","author":"Qin","year":"2015","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13058-023-01617-4","article-title":"Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin","volume":"25","author":"Saeki","year":"2023","journal-title":"Breast Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"8398","DOI":"10.3748\/wjg.v21.i27.8398","article-title":"SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis","volume":"21","author":"Wang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41568-019-0237-2","article-title":"Nerves in cancer","volume":"20","author":"Zahalka","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.biopha.2018.07.099","article-title":"Synthetic human monoclonal antibody targets hIL1 receptor accessory protein chain with therapeutic potential in triple-negative breast cancer","volume":"107","author":"Zheng","year":"2018","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1900123\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:53:03Z","timestamp":1787921583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1900123\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":29,"alternative-id":["10.3389\/fbioe.2026.1900123"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2026.1900123","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"1900123"}}